LSV Asset Management’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-33,508
Closed -$531K 981
2018
Q4
$531K Sell
33,508
-7,779
-19% -$134K ﹤0.01% 840
2018
Q3
$776K Sell
41,287
-3,401
-8% -$67.7K ﹤0.01% 830
2018
Q2
$859K Hold
44,688
﹤0.01% 816
2018
Q1
$924K Sell
44,688
-600
-1% -$12.5K ﹤0.01% 815
2017
Q4
$931K Buy
45,288
+14,600
+48% +$271K ﹤0.01% 798
2017
Q3
$565K Buy
30,688
+4,284
+16% +$94.3K ﹤0.01% 853
2017
Q2
$658K Buy
26,404
+17,404
+193% +$366K ﹤0.01% 838
2017
Q1
$180K Buy
+9,000
New +$198K ﹤0.01% 959

Other funds holding PMD

LSV Asset Management's PMD Position: Q1 2019 in Review

LSV Asset Management sold out of Psychemedics Corporation (PMD) in Q1 2019, closing a stake of 33,508 shares — an estimated $531K sold.

LSV Asset Management first reported a position in PMD in Q1 2017 and held it in 8 quarters. The position peaked at $931K in Q4 2017. 52 funds tracked by Wall St. Rank hold PMD as of Q1 2019.

  • LSV Asset Management reported no remaining Psychemedics Corporation position as of Q1 2019 after selling out during the quarter.
  • LSV Asset Management sold 33,508 Psychemedics Corporation shares in Q1 2019, an estimated $531K.
  • LSV Asset Management first reported a position in Psychemedics Corporation in Q1 2017 and held it in 8 quarters.
  • LSV Asset Management's Psychemedics Corporation position peaked at $931K in Q4 2017.
  • 52 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2019.

Based on LSV Asset Management's 13F filing for Q1 2019, filed 7 May 2019.